This study aims to explore the relationship between blood lactate levels and outcomes in Amyotrophic Lateral Sclerosis (ALS).
Measured blood lactate levels in ALS patients
Evaluated the association with survival rates and weight loss
Performed statistical analyses to validate findings
Lower blood lactate levels correlate with higher risk of earlier death
Patients with lower lactate experience greater weight loss
Blood lactate shows potential as a biomarker for nutritional status in ALS
Abstract
Lower blood lactate is associated with increased risk for earlier death and greater weight loss in ALS, suggesting that lactate is a prognostic biomarker of nutritional status. ANN NEUROL 2026.